Keryx Biopharmaceuticals $14.84

down -0.35


11/7/2014 04:24 PM  |  NASDAQ : KERX  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get KERX Trend Analysis - it has outperformed the S&P 500 by 69%

Partner Headlines

  1. Seth Klarman Tops Guru Scoreboard for First Half 2014

    GuruFocus
  2. Seth Klarman Is Top-Performing Guru for First Half 2014

    GuruFocus
  3. Morning Market Movers

    Benzinga
  4. Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals

    GuruFocus
  5. UPDATE: MLV & Co Reiterates On Keryx Biopharmaceuticals On Increased Risk

    Benzinga
  6. Keryx Biopharma Reports Zerenex Phase 2 Results in Non-Dialysis Dependent ...

    Benzinga
  7. Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization ...

    Benzinga
  8. Mid-Afternoon Market Update: Markets Turn Red as Dish Network Rises

    Benzinga
  9. Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis Shares ...

    Benzinga
  10. Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD

    GuruFocus
  11. Kiplinger's Tom Petruno Breaks Down The Best Bull Market Stocks

    Benzinga
  12. Keryx Prices 6.9M Share Offering at $14.50/Share

    Benzinga
  13. Keryx UPDATE: Biopharmaceuticals Announces $90M Proposed Public Offering ...

    Benzinga
  14. Weekly Insider Sells Highlight: FLT, KERX, KOG, MEI, HTZ

    GuruFocus
  15. Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV

    IBD
  16. UPDATE: J.P. Morgan Reiterates on Keryx Biopharmaceuticals on Model Update ...

    Benzinga
  17. Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination ...

    Benzinga
  18. UPDATE: JMP Securities Reiterates on Keryx Biopharmaceuticals on Blockbuster ...

    Benzinga
  19. Keryx Says FDA Accepted Filing for Zerenex NDA

    Benzinga
  20. UPDATE: H.C. Wainwright Initiates Coverage on Keryx Biopharmaceuticals ...

    Benzinga
  21. Market Wrap for Tuesday, January 29: Dow and S&P Record Solid Gains, Nasdaq ...

    Benzinga
  22. UPDATE: Oppenheimer Raises PT to $11 on KERYX Biopharmaceuticals; Zerenex ...

    Benzinga
  23. Market Wrap for Monday, January 28: Dow and S&P Fall Slightly; Nasdaq Records ...

    Benzinga
  24. Morning Market Movers

    Benzinga
  25. Keryx Biopharma Says Trial on Zerenex Met Primary, Secondary Key Endpoints

    Benzinga
  26. Keryx Biopharmaceuticals to Discuss Top-Line Results from Zerenex Phase ...

    Benzinga
  27. Keryx Biopharmaceuticals, Inc. (KERX) CFO James F Iii Oliviero sells 1 ...

    GuruFocus
  28. Keryx Biopharmaceuticals, Inc. (KERX) CEO Ron Bentsur sells 6,010 Shares

    GuruFocus
  29. Dawson James Securities Reiterates Market Outperform Rating, $4 PT on Keryx ...

    Benzinga
  30. Keryx Biopharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  31. Keryx Biopharmaceuticals Inc. (KERX) CFO James F Iii Oliviero sells 4,973 ...

    GuruFocus
  32. Keryx Biopharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  33. Keryx Biopharmaceuticals Inc. (KERX) CFO James F Iii Oliviero sells 4,559 ...

    GuruFocus
  34. Lan Airlines, VimpelCom Among Stocks Down on Above-average Volume Thursday

    FoxBusiness
  35. Benzinga's Top Upgrades with Color for May 10, 2012

    Benzinga
  36. UPDATE: Ladenburg Thalmann Upgrades Keryx Biopharmaceuticals; Establishes ...

    Benzinga
  37. Stock Futures Point to Weak Start for the Quarter with Avon Products (AVP) ...

    MarketIntelligenceCenter
  38. Morning Social Media Outlook for Tuesday Mar 6 (SHFL, HAR, PCX, NTRI)

    Benzinga
  39. Keryx Biopharma Trade Lower after Adam Feuerstein's Negative Blog Post

    Benzinga
  40. FDA Approval Practically A Done Deal For Keryx And AEterna Zentaris -SeekingAlpha

    Benzinga
  41. Notable Put Options Activity in Keryx Biopharmaceuticalskerx

    Benzinga
  42. Keryx Biopharmaceuticals (KERX) Falls 1.9% as Put-Call Ratio Rises Above ...

    MarketIntelligenceCenter
  43. Keryx Biopharmaceuticals Inc. (KERX) CFO James F Iii Oliviero sells 7,19 ...

    GuruFocus
  44. Keryx Biopharmaceuticals Inc. (KERX) CEO Ron Bentsur sells 3,305 Shares

    GuruFocus
  45. Notable Put Options Activity in Keryx Biopharmaceuticals

    Benzinga
  46. BoardCentral StockTalk - weekly update: BRKA, AAPL, AMD, KERX, KERX, KERX, ...

    BoardCentral
  47. Notable Put Options Activity in Keryx Biopharmaceuticals

    Benzinga
  48. Notable Put Options Activity in KLA-Tencor

    Benzinga
Trading Center